SCHEMBL653324

SCHEMBL653324

COc1cc(C(=O)O)ccc1N=C1NC(=O)C(=Cc2cnc(NC(=O)CCC(=O)O)s2)S1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
POLB P06746 4/20 0.41
PTPN7 P35236 2/20 0.40
PTPN12 Q05209 2/20 0.40
PTPN22 Q9Y2R2 2/20 0.40
PTP4A3 O75365 1/20 0.39
MAP4K4 O95819 3/20 0.39
PIM1 P11309 3/20 0.39
DYRK1A Q13627 3/20 0.39
PIM3 Q86V86 3/20 0.39
MKNK2 Q9HBH9 3/20 0.39
CDC7 O00311 2/20 0.39
PLK4 O00444 2/20 0.39
DAPK3 O43293 2/20 0.39
DYRK3 O43781 2/20 0.39
PRKD3 O94806 2/20 0.39
CDK1 P06493 2/20 0.39
LYN P07948 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653323 1.00 HSD11B1 (0.42) HSD11B1MEN1KMT2APOLBPTPN7
SCHEMBL652083 0.89 KMT2A (0.52) HSD11B1MEN1KMT2APOLBPTPN7
SCHEMBL652084 0.89 KMT2A (0.52) HSD11B1MEN1KMT2APOLBPTPN7
SCHEMBL650340 0.85 MAPT (0.45) MEN1KMT2APOLBPTP4A3PIM1
SCHEMBL650341 0.85 MAPT (0.45) MEN1KMT2APOLBPTP4A3PIM1
SCHEMBL649045 0.84 MEN1 (0.46) MEN1KMT2APOLBPTPN7PTPN12
SCHEMBL649044 0.84 MEN1 (0.46) MEN1KMT2APOLBPTPN7PTPN12
SCHEMBL651164 0.83 MAPT (0.52) MEN1KMT2APOLBPTP4A3MAPT
SCHEMBL651165 0.83 MAPT (0.52) MEN1KMT2APOLBPTP4A3MAPT
SCHEMBL651383 0.83 RNASEL (0.43) MEN1KMT2APOLBPTP4A3GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 HSD11B1 972/4885MEN1 1406/4885KMT2A 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.